{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-21-287318","form_type":"8-K","ticker":"NRIX","cik":"0001549595","company_name":"Nurix Therapeutics, Inc.","filed_at":"2021-09-30T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.533052+00:00","generated_at":"2026-06-29T00:23:07.333199+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Nurix Therapeutics names Judith Reinsdorf and Paul Silva to board, effective Oct 1","bullets":["Judith Reinsdorf appointed to board and Governance Committee; Paul Silva to Audit Committee.","Each receives initial option to purchase 35,000 shares vesting over three years.","Reinsdorf is former EVP & GC of Johnson Controls; Silva is former SVP & CAO of Vertex.","Appointments effective Oct 1, 2021; both also receive pro-rata cash retainers."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-21-287318","json":"https://secwatch.observer/filing/0001193125-21-287318.json","markdown":"https://secwatch.observer/filing/0001193125-21-287318.md","text":"https://secwatch.observer/filing/0001193125-21-287318.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/d225615d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T00:23:07.333199+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"7d2b022434","claim":"Judith A. Reinsdorf was appointed as Director at Nurix Therapeutics, Inc..","evidence_excerpt":"appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"d57c5b784c","claim":"Paul M. Silva was appointed as Director at Nurix Therapeutics, Inc..","evidence_excerpt":"appointed each of Judith A. Reinsdorf and Paul M. Silva to serve as a director of the Company, effective October 1, 2021","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1549595/000119312521287318/0001193125-21-287318-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}